These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18503256)

  • 21. No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III.
    McGrath J; Scragg R; Chant D; Eyles D; Burne T; Obradovic D
    Neuroepidemiology; 2007; 29(1-2):49-54. PubMed ID: 17898524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D and Alzheimer's disease: is there a link?
    Pogge E
    Consult Pharm; 2010 Jul; 25(7):440-50. PubMed ID: 20601349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure, dementia and Alzheimer's disease: the OPTIMA longitudinal study.
    Razay G; Williams J; King E; Smith AD; Wilcock G
    Dement Geriatr Cogn Disord; 2009; 28(1):70-4. PubMed ID: 19648748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin B(12) supplementation did not improve cognition but reduced delirium in demented patients with vitamin B(12) deficiency.
    Kwok T; Lee J; Lam L; Woo J
    Arch Gerontol Geriatr; 2008; 46(3):273-82. PubMed ID: 17561285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease.
    Muck-Seler D; Presecki P; Mimica N; Mustapic M; Pivac N; Babic A; Nedic G; Folnegovic-Smalc V
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1226-31. PubMed ID: 19602426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rate of MMSE score change in Alzheimer's disease: influence of education and vascular risk factors.
    Roselli F; Tartaglione B; Federico F; Lepore V; Defazio G; Livrea P
    Clin Neurol Neurosurg; 2009 May; 111(4):327-30. PubMed ID: 19036496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.
    Buchhave P; Janciauskiene S; Zetterberg H; Blennow K; Minthon L; Hansson O
    Neurosci Lett; 2009 Jan; 450(1):56-9. PubMed ID: 18996438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive decline from estimated premorbid status predicts neurodegeneration in Alzheimer's disease.
    Almkvist O; Tallberg IM
    Neuropsychology; 2009 Jan; 23(1):117-24. PubMed ID: 19210039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cross-sectional and longitudinal study of the relationship between walking speed and cognitive function in community-dwelling elderly people.
    Soumaré A; Tavernier B; Alpérovitch A; Tzourio C; Elbaz A
    J Gerontol A Biol Sci Med Sci; 2009 Oct; 64(10):1058-65. PubMed ID: 19561146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.
    Verwey NA; Schuitemaker A; van der Flier WM; Mulder SD; Mulder C; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R
    Dement Geriatr Cogn Disord; 2008; 26(6):522-7. PubMed ID: 19052452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum magnesium level and clinical deterioration in Alzheimer's disease.
    Cilliler AE; Ozturk S; Ozbakir S
    Gerontology; 2007; 53(6):419-22. PubMed ID: 17992016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Korean version of the Baylor Profound Mental Status Examination: a brief staging measure for patients with severe Alzheimer's disease.
    Na HR; Lee SH; Lee JS; Doody RS; Kim SY
    Dement Geriatr Cogn Disord; 2009; 27(1):69-75. PubMed ID: 19145080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of multisensory stimulation on cognition, depression and anxiety levels of mildly-affected Alzheimer's patients.
    Ozdemir L; Akdemir N
    J Neurol Sci; 2009 Aug; 283(1-2):211-3. PubMed ID: 19289242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease.
    Deschaintre Y; Richard F; Leys D; Pasquier F
    Neurology; 2009 Sep; 73(9):674-80. PubMed ID: 19720973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between the regional cerebral blood flow and the cognitive function and anosmia in patients with Parkinson disease and Alzheimer disease].
    Imamura K; Matumoto S; Mabuchi N; Kobayashi Y; Okayasu N; Watanabe K
    Brain Nerve; 2009 Jun; 61(6):683-90. PubMed ID: 19526836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular disease risk factors and progression of Alzheimer's disease.
    Abellan van Kan G; Rolland Y; Nourhashémi F; Coley N; Andrieu S; Vellas B
    Dement Geriatr Cogn Disord; 2009; 27(3):240-6. PubMed ID: 19246908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stress and coping in older people with Alzheimer's disease.
    de Souza-Talarico JN; Chaves EC; Nitrini R; Caramelli P
    J Clin Nurs; 2009 Feb; 18(3):457-65. PubMed ID: 19077019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.
    Wattmo C; Hansson O; Wallin AK; Londos E; Minthon L
    Dement Geriatr Cogn Disord; 2008; 26(3):203-11. PubMed ID: 18769065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.